Search Results - "von Baby, Becca"

Impact of novel pan-RAS inhibitors on efficacy and resistance to AMG-510 and MRTX-1133 in pancreatic cancer cell lines by Arshad, Tariq, Donninger, Howard, von Baby, Becca, Ferrill, Rachel, Burlison, Joe, Trent, John, Clark, Geoffrey J.

“…4155 Background: Mutant-activated RAS genes are the most frequently mutated gene family associated with cancer (almost 30% of all cancers contain a mutant RAS…”
Get full text

Abstract 3930: Chemoprevention of metastatic colon cancer by a novel small molecule by Pal, Deeksha, Chandrasekaran, Balaji, Tyagi, Ashish, Baby, Becca Von, Alatassi, Houda, Ankem, Murali, Damodaran, Chendil

“…Abstract Introduction: Colon cancer is a one of the leading cause of death in both men and women. Metastatic colon cancer is responsible for mortality due to…”
Get full text

Abstract 3097: Chemo prevention effect of Withaferin A, a natural compound, on mouse models of colorectal carcinogenesis by Pal, Deeksha, Chandrasekaran, Balaji, Baby, Becca Von, Alatassi, Houda, Ankem, Murali, Damodaran, Chendil

“…Abstract Introduction: Colorectal cancer (CRC) is the most common cancer and one of the leading causes of cancer-related deaths in United States as well as…”
Get full text

Abstract 4894: Identification of small molecules for the prevention and treatment of colon cancer by Pal, Deeksha, Baby, Becca Von, Chandrasekaran, Balaji, Sharma, Arun, Damodaran, Chendil

“…Abstract Metastatic colon cancer or colorectal cancer (CRC) is associated with poor survival rate which is less than 5% due to chemo resistance. We previously…”
Get full text

Abstract 2598: Developing small molecule inhibitors that target androgen receptor signaling in castration-resistant prostate cancer by Chandrasekaran, Balaji, Tyagi, Ashish, Kolluru, Venkatesh, Vadhanam, Aakash M., Baby, Becca von, Gorle, Suresh, Sirimulla, Suman, Ramisetti, Srinivasa R., Sharma, Arun K., Ankem, Murali K, damodaran, Chendil

“…Abstract The transcription factor, androgen receptor (AR) is a key driver and plays an important role in prostate cancer. Androgen ablation therapy and…”
Get full text

Abstract B005: RAS inhibitors to treat luminal B breast cancer by Clarke, Geoff, Donninger, Howard, Jigo, Raphael, Arshad, Tariq, von Baby, Becca, Ferrill, Rachel, Sabo, Mike, Burlison, Joe, Trent, John

“…Abstract Since RAS mutations are rare in Breast Cancer, RAS has not traditionally been considered as an important driver of this disease. However, RAS…”
Get full text

Abstract B006: Novel direct RAS inhibitors for pancreatic cancer by Clarke, Geoff, Arshad, Tariq, Donninger, Howard, von Baby, Becca, Ferrill, Rachel, Sabo, Mike, Burlison, Joe, Trent, John

“…Abstract RAS oncogenes are frequently activated by mutations in pancreatic and lung cancer, where they appear to act as driving mutations. This study examines…”
Get full text

Targeted delivery of microbial metabolite, urolithin A protects from chemically (DSS or TNBS) induced colitis in pre-clinical models by Singh, Rajbir, Hegde, Bindu, Von Baby, Becca, Sadeep, C, Kotla, Niranjan, Chandrasekar, Bhargavi, Marepally, Srujan, Bodduluri, Haribabu, Vemula, Praveen K, Jala, Venkatakrishna R

“…Abstract Epidemiological data suggests that consumption of diets rich in phytochemicals are protective in inflammatory bowel diseases (IBDs). However, the…”
Get full text